Ocaratuzumab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ocaratuzumab, covering 2014-03-03 to 2014-03-03. Get the full timeline:
Most recent: Clinical Trial Update: Phase I Study of Subcutaneous Ocaratuzumab in Patients With Previously Treated CD20+ B-Cell Malignancies [Phase 1]